However, in April 2026, the PIL for Tirzepatide as Mounjaro was updated to state Tirzepatide passes into breastmilk in very low amounts and is not expected to be absorbed by a breastfed newborn/infant
Providers monitor for side effects, which can appear when starting the drug, and monitor for uncommon symptoms such as dysesthesia
The Alabama action also demonstrates a growing willingness among state attorneys general to intervene when the FDA has not yet taken action
Semaglutide color changes like cloudiness, particulate matter, or discoloration indicate advanced breakdown
Findings are preliminary, and more research is needed to understand this risk
Yes, but you must carry it in your hand luggage not checked baggage using a validated medical-grade cool bag with a temperature logger, and bring a letter from your trial site confirming its status as a clinical trial medicine